| Authors: |
Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Tsuchihashi K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Baba E; Department of Comprehensive Oncology, Kyushu University, 3-1-1 Maidashi, Fukuoka, 812-8582, Japan., Takahashi M; Department of Medical Oncology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai-shi, Miyagi, 980-8574, Japan., Kinoshita I; Division of Clinical Cancer Genomics, Hokkaido University Hospital, North14, West 5, Kita-ku, Sapporo 060-8648, Japan., Muto M; Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan., Kamikura M; Clinical Research Support Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Sadachi R; Clinical Research Support Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Shibata T; Clinical Research Support Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Ichimura M; Clinical Research Support Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Sakamoto W; Real World Evidence Japan, Nippon Boehringer Ingelheim Co., Ltd, 2-1-1 Osaki, Shinagawa-ku, Tokyo, 141-6017, Japan., Hirata Y; Department of Medicine, Nippon Boehringer Ingelheim Co., Ltd, 2-1-1 Osaki, Shinagawa-ku, Tokyo, 141-6017, Japan., Nakamura K; Department of International Clinical Development, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Yonemori K; Department of International Clinical Development, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. |
